Transient receptor potential canonical 6 (TRPC6) channel inhibition mitigates tubular injury and renal fibrosis in murine models of unilateral ureteral obstruction (UUO) and 2‐month chronic post–ischemia‐reperfusion injury (2m post‐I/R). The gene discussed is TRPC6; the disease is renal fibrosis.